A review of sodium oxybate and baclofen in the treatment of sleep disorders.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Current pharmaceutical design

• Publication date

  2011-05-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.2174/138161211796197098PMID 21476957
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Differential Effects of GABAB Receptor Subtypes, γ-Hydroxybutyric Acid, and Baclofen on EEG Activity and Sleep Regulation

  2010cited by this paper
• The importance of a good night's sleep: an open-label trial of the sodium salt of gamma-hydroxybutyric acid in insomnia associated with schizophrenia.

  2010cited by this paper
• Enhancing slow wave sleep with sodium oxybate reduces the behavioral and physiological impact of sleep loss.

  2010cited by this paper
• Behavioral effects of γ-hydroxybutyrate in humans

  2010cited by this paper
• γ‐Hydroxybutyrate and the GABAergic footprint: a metabolomic approach to unpicking the actions of GHB

  2010cited by this paper
• Successful Treatment of REM Sleep Behavior Disorder With Sodium Oxybate

  2009cited by this paper
• Narcolepsy: action of two gamma-aminobutyric acid type B agonists, baclofen and sodium oxybate.

  2009cited by this paper
• Sodium oxybate relieves pain and improves function in fibromyalgia syndrome: a randomized, double-blind, placebo-controlled, multicenter clinical trial.

  2009cited by this paper
• GABAB Receptors, Schizophrenia and Sleep Dysfunction

  2009cited by this paper
• Cognitive, psychomotor, and subjective effects of sodium oxybate and triazolam in healthy volunteers

  2009cited by this paper
• The effect of baclofen on alterations in the sleep patterns induced by different stressors in rats.

  2009cited by this paper
• The distribution of gamma-hydroxybutyrate-induced Fos expression in rat brain: comparison with baclofen.

  2009cited by this paper
• The nightly administration of sodium oxybate results in significant reduction in the nocturnal sleep disruption of patients with narcolepsy.

  2009cited by this paper
• Cloning and functional characterization of a gamma‐hydroxybutyrate receptor identified in the human brain

  2007cited by this paper
• Improved sleep and neurocognitive functions in a child with thalamic lesions on sodium oxybate

  2007cited by this paper
• A randomized trial evaluating the effectiveness of sodium oxybate therapy on quality of life in narcolepsy.

  2006cited by this paper
• Off-label treatment of severe childhood narcolepsy-cataplexy with sodium oxybate.

  2006cited by this paper
• Sodium oxybate improves excessive daytime sleepiness in narcolepsy.

  2006cited by this paper
• Intrathecal baclofen overdose followed by withdrawal: clinical and EEG features.

  2005cited by this paper
• Sodium oxybate demonstrates long-term efficacy for the treatment of cataplexy in patients with narcolepsy.

  2004cited by this paper
• A pilot study on the effects of sodium oxybate on sleep architecture and daytime alertness in narcolepsy.

  2004cited by this paper
• gamma-hydroxybutyrate increases a potassium current and decreases the H-current in hippocampal neurons via GABAB receptors.

  2004cited by this paper
• Spontaneous REM sleep is modulated by the activation of the pedunculopontine tegmental GABAB receptors in the freely moving rat.

  2004cited by this paper
• Specific gamma-hydroxybutyrate-binding sites but loss of pharmacological effects of gamma-hydroxybutyrate in GABA(B)(1)-deficient mice.

  2003cited by this paper
• The effects of sodium oxybate on clinical symptoms and sleep patterns in patients with fibromyalgia.

  2003cited by this paper
• Sleep is differently modulated by basal forebrain GABA(A) and GABA(B) receptors.

  2001cited by this paper
• Evidence for a G protein-coupled gamma-hydroxybutyric acid receptor.

  2000cited by this paper
• Gamma-hydroxybutyrate is a weak agonist at recombinant GABA(B) receptors.

  1999cited by this paper
• Neurochemical and electrophysiological evidence for the existence of a functional gamma-hydroxybutyrate system in NCB-20 neurons.

  1998cited by this paper
• Effect of gamma-hydroxybutyrate on pain, fatigue, and the alpha sleep anomaly in patients with fibromyalgia. Preliminary report.

  1998cited by this paper
• Binding characteristics of gamma-hydroxybutyric acid as a weak but selective GABAB receptor agonist.

  1997cited by this paper
• Simultaneous stimulation of slow-wave sleep and growth hormone secretion by gamma-hydroxybutyrate in normal young Men.

  1997cited by this paper
• The effects of the GABA agonist, baclofen, on sleep and breathing.

  1995cited by this paper
• Clinical and genetic studies of fatal familial insomnia

  1995cited by this paper
• Narcolepsy in children.

  1994cited by this paper
• The pharmacology and function of central GABAB receptors.

  1994cited by this paper
• Blockade of thalamic GABAB receptors decreases EEG synchronization.

  1994cited by this paper
• Gammahydroxybutyrate and narcolepsy: a double-blind placebo-controlled study.

  1993cited by this paper
• The effect of gamma-hydroxybutyrate on nocturnal and diurnal sleep of normal subjects: further considerations on REM sleep-triggering mechanisms.

  1990cited by this paper
• The effects of gamma-hydroxybutyrate on the sleep of narcolepsy patients: a double-blind study.

  1990cited by this paper
• Efficacy of gamma-hydroxybutyrate versus placebo in treating narcolepsy-cataplexy: double-blind subjective measures.

  1989cited by this paper
• In vivo conversion of gamma-aminobutyric acid and 1,4-butanediol to gamma-hydroxybutyric acid in rat brain. Studies using stable isotopes.

  1989cited by this paper
• The effects and effectiveness of gamma-hydroxybutyrate in patients with narcolepsy.

  1985cited by this paper
• Effect of baclofen on sleep‐related periodic leg movements

  1984cited by this paper
• Gamma-hydroxybutyric acid binding sites in rat and human brain synaptosomal membranes.

  1984cited by this paper
• Effects of Nocturnal Gamma-Hydroxybutyrate on Sleep/Waking Patterns in Narcolepsy-Cataplexy

  1980cited by this paper
• The Treatment of Narcolepsy-Cataplexy with Nocturnal Gamma-Hydroxybutyrate

  1979cited by this paper
• PURIFICATION FROM HUMAN BRAIN AND SOME PROPERTIES OF TWO NADPH‐LINKED ALDEHYDE REDUCTASES WHICH REDUCE SUCCINIC SEMIALDEHYDE TO 4‐HYDROXYBUTYRATE

  1979cited by this paper
• Identification of endogenous gamma-hydroxybutyrate in human and bovine brain and its regional distribution in human, guinea pig and rhesus monkey brain.

  1978cited by this paper
• Baclofen, a new antispastic drug. A controlled, multicenter trial in patients with multiple sclerosis.

  1977cited by this paper
• The effects of gamma-hydroxybutyrate on sleep.

  1977cited by this paper
• Musculosketal Symptoms and Non‐REM Sleep Disturbance in Patients with “Fibrositis Syndrome” and Healthy Subjects

  1975cited by this paper
• Sleep-inducing effects of gammahydroxybutyrate.

  1973cited by this paper
• Baclofen in the Treatment of Spasticity*

  1971cited by this paper
• Conversion in vivo of gamma-aminobutyric to gamma-hydroxybutyric acid in the rat.

  1969cited by this paper
• Human growth hormone release: relation to slow-wave sleep and sleep-walking cycles.

  1969cited by this paper
• Dependence of rat serum lactonase upon calcium.

  1967cited by this paper
• Effect of butyrolactone and gamma-hydroxybutyrate on the EEG and sleep cycle in man.

  1967cited by this paper
• An EEG-behavioral study of sodium hydroxybutyrate in humans.

  1966cited by this paper
• PRELIMINARY REPORT ON THE METABOLISM OF GAMMA-BUTYROLACTONE AND GAMMA-HYDROXYBUTYRIC ACID.

  1965cited by this paper
• SODIUM 4-HYDROXYBUTYRATE.

  1964cited by this paper
• Gamma-Hydroxybutyrate, a Normal Brain Metabolite

  1963cited by this paper

• MANAGEMENT OF FIBROMYALGIA: A COMPREHENSIVE REVIEW OF ESTABLISHED AND EMERGING THERAPEUTIC STRATEGIES AND PATHOPHYSIOLOGICAL MECHANISMS

  2025cites this paper
• Pharmacological Treatment of Fibromyalgia Syndrome: A Practice-Based Review

  2024cites this paper
• Healthy Sleep, Orexin System and Addiction

  2024cites this paper
• Co-existing Sleep Disorders: Overcoming Challenges Through Effective Management

  2024cites this paper
• Drugs Used in Narcolepsy and Other Hypersomnias.

  2022cites this paper
• The Role of Orexin-1 Receptors Within the Hippocampal CA1 Area in the Extinction and Reinstatement of Methamphetamine-Seeking Behaviors

  2022cites this paper
• Evaluation of the Efficacy of the Hypocretin/orexin Receptor Agonists TAK-925 and ARN-776 in Narcoleptic Orexin/tTA; TetO-DTA Mice

  2022cites this paper
• Pleasure, addiction, and hypocretin (orexin).

  2021cites this paper
• Hypocretin/Orexin Interactions with Norepinephrine Contribute to the Opiate Withdrawal Syndrome

  2021cites this paper
• Phase I metabolites (organic acids) of gamma-hydroxybutyric acid -validated quantification by GC-MS and description of endogenous concentration ranges.

  2020cites this paper
• The effect of baclofen on objective and subjective sleep measures in a model of transient insomnia.

  2020cites this paper
• A novel GABAB receptor positive allosteric modulator, ASP8062, exerts analgesic effects in a rat model of fibromyalgia.

  2019cites this paper
• Management of Excessive Daytime Sleepiness in Narcolepsy With Baclofen.

  2019cites this paper
• Update on the pharmacologic management of narcolepsy: mechanisms of action and clinical implications.

  2019cites this paper
• Baclofen‐induced encephalopathy in overdose – Modeling of the electroencephalographic effect/concentration relationships and contribution of tolerance in the rat

  2018influential citation
• Drugs Used in Narcolepsy and Other Hypersomnias.

  2018cites this paper
• Direct activation of G-protein-gated inward rectifying K+ channels promotes nonrapid eye movement sleep

  2018cites this paper
• Challenges in the development of therapeutics for narcolepsy.

  2017cites this paper
• Case Studies in Medical Toxicology

  2017cites this paper
• Case 19 Nicotine Toxicity

  2017cites this paper
• Neurobiology of REM Sleep, NREM Sleep Homeostasis, and Gamma Band Oscillations

  2017cites this paper
• Chapter 4 – Soporific Agents (Hypnotics and Sedative Drugs)

  2016cites this paper
• N(6)-(3-methoxyl-4-hydroxybenzyl) adenine riboside induces sedative and hypnotic effects via GAD enzyme activation in mice.

  2014cites this paper
• GABAB Agonism Promotes Sleep and Reduces Cataplexy in Murine Narcolepsy

  2014cites this paper
• Drug-induced sleep: theoretical and practical considerations

  2011cites this paper
• Innovative Technologies in Social

  year unknowncites this paper